265 related articles for article (PubMed ID: 27862031)
21. Utility and Results from a Patient-Reported Online Survey in Myotonic Dystrophies Types 1 and 2.
Wenninger S; Stahl K; Montagnese F; Schoser B
Eur Neurol; 2020; 83(5):523-533. PubMed ID: 33120389
[TBL] [Abstract][Full Text] [Related]
22. Fatigue and daytime sleepiness in patients with myotonic dystrophy type 1: to lump or split?
Laberge L; Dauvilliers Y; Bégin P; Richer L; Jean S; Mathieu J
Neuromuscul Disord; 2009 Jun; 19(6):397-402. PubMed ID: 19403309
[TBL] [Abstract][Full Text] [Related]
23. Change over time in ability to perform activities of daily living in myotonic dystrophy type 1.
Landfeldt E; Nikolenko N; Jimenez-Moreno C; Cumming S; Monckton DG; Faber CG; Merkies ISJ; Gorman G; Turner C; Lochmüller H
J Neurol; 2020 Nov; 267(11):3235-3242. PubMed ID: 32542526
[TBL] [Abstract][Full Text] [Related]
24. Picturing the Experience of Living With Myotonic Dystrophy (DM1): A Qualitative Exploration Using Photovoice.
LaDonna KA; Venance SL
J Neurosci Nurs; 2015 Oct; 47(5):285-95. PubMed ID: 26348433
[TBL] [Abstract][Full Text] [Related]
25. Psychological characteristics of patients with myotonic dystrophy type 1.
Bertrand JA; Jean S; Laberge L; Gagnon C; Mathieu J; Gagnon JF; Richer L
Acta Neurol Scand; 2015 Jul; 132(1):49-58. PubMed ID: 25496310
[TBL] [Abstract][Full Text] [Related]
26. Cognitive impairment and quality of life in patients with myotonic dystrophy type 1.
Fujino H; Shingaki H; Suwazono S; Ueda Y; Wada C; Nakayama T; Takahashi MP; Imura O; Matsumura T
Muscle Nerve; 2018 May; 57(5):742-748. PubMed ID: 29193182
[TBL] [Abstract][Full Text] [Related]
27. Further evidence for the reliability and validity of the Fatigue and Daytime Sleepiness Scale.
Gallais B; Gagnon C; Forgues G; Côté I; Laberge L
J Neurol Sci; 2017 Apr; 375():23-26. PubMed ID: 28320135
[TBL] [Abstract][Full Text] [Related]
28. Sleep disorders in myotonic dystrophy type 2: a controlled polysomnographic study and self-reported questionnaires.
Romigi A; Albanese M; Placidi F; Izzi F; Liguori C; Marciani MG; Mercuri NB; Terracciano C; Vitrani G; Petrucci A; Di Gioia B; Massa R
Eur J Neurol; 2014 Jun; 21(6):929-34. PubMed ID: 23837695
[TBL] [Abstract][Full Text] [Related]
29. Health-related quality of life in patients with myotonic dystrophy type 1 and amyotrophic lateral sclerosis.
Peric' S; Rakocevic-Stojanovic V; Stevic Z; Basta I; Pavlovic S; Vujanac V; Marjanovic L; Lavrnic D
Acta Neurol Belg; 2010 Mar; 110(1):71-7. PubMed ID: 20514929
[TBL] [Abstract][Full Text] [Related]
30. Activities of daily living in myotonic dystrophy type 1.
Landfeldt E; Nikolenko N; Jimenez-Moreno C; Cumming S; Monckton DG; Faber CG; Merkies ISJ; Gorman G; Turner C; Lochmüller H
Acta Neurol Scand; 2020 May; 141(5):380-387. PubMed ID: 31889295
[TBL] [Abstract][Full Text] [Related]
31. Participation and the Role of Neuropsychological Functioning in Myotonic Dystrophy Type 1.
Van Heugten C; Meuleman S; Hellebrekers D; Kruitwagen-van Reenen E; Visser-Meily J
J Neuromuscul Dis; 2018; 5(2):205-214. PubMed ID: 29865086
[TBL] [Abstract][Full Text] [Related]
32. Disease awareness in myotonic dystrophy type 1: an observational cross-sectional study.
Baldanzi S; Bevilacqua F; Lorio R; Volpi L; Simoncini C; Petrucci A; Cosottini M; Massimetti G; Tognoni G; Ricci G; Angelini C; Siciliano G
Orphanet J Rare Dis; 2016 Apr; 11():34. PubMed ID: 27044540
[TBL] [Abstract][Full Text] [Related]
33. [Sleep disorders and fatigue in patients with different forms of myotonic dystrophy type 1].
Erokhina EK; Melnik EA; Lebedeva DD; Shamtieva KV; Peters TV; Pavlikova EP; Gepard VV; Vlodavets DV
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(8):62-67. PubMed ID: 37655412
[TBL] [Abstract][Full Text] [Related]
34. Quality of life and excessive daytime sleepiness in children and adolescents with myotonic dystrophy type 1.
Ho G; Widger J; Cardamone M; Farrar MA
Sleep Med; 2017 Apr; 32():92-96. PubMed ID: 28366348
[TBL] [Abstract][Full Text] [Related]
35. Reliability of the Apathy Evaluation Scale in Myotonic Dystrophy Type 1.
Gallais B; Gagnon C; Côté I; Forgues G; Laberge L
J Neuromuscul Dis; 2018; 5(1):39-46. PubMed ID: 29278897
[TBL] [Abstract][Full Text] [Related]
36. Quality of life and subjective symptom impact in Japanese patients with myotonic dystrophy type 1.
Fujino H; Saito T; Takahashi MP; Takada H; Nakayama T; Imura O; Matsumura T
BMC Neurol; 2022 Feb; 22(1):55. PubMed ID: 35164706
[TBL] [Abstract][Full Text] [Related]
37. Quality of instruments assessing activity and participation of people with muscular dystrophy: A systematic review of participant-reported outcome measures.
Andrade KKS; Soares LA; Macedo CC; Bispo NR; Sousa Junior RR; Oliveira VC; Leite HR; Gaiad TP
Dev Med Child Neurol; 2022 Dec; 64(12):1453-1461. PubMed ID: 35862363
[TBL] [Abstract][Full Text] [Related]
38. Clinical, psychosocial, and central correlates of quality of life in myotonic dystrophy type 1 patients.
Laberge L; Mathieu J; Auclair J; Gagnon É; Noreau L; Gagnon C
Eur Neurol; 2013; 70(5-6):308-15. PubMed ID: 24158106
[TBL] [Abstract][Full Text] [Related]
39. Fatigue and daytime sleepiness scale in myotonic dystrophy type 1.
Hermans MC; Merkies IS; Laberge L; Blom EW; Tennant A; Faber CG
Muscle Nerve; 2013 Jan; 47(1):89-95. PubMed ID: 23042586
[TBL] [Abstract][Full Text] [Related]
40. Functioning and disability in adults with myotonic dystrophy type 1.
Kierkegaard M; Harms-Ringdahl K; Holmqvist LW; Tollbäck A
Disabil Rehabil; 2011; 33(19-20):1826-36. PubMed ID: 21254917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
